Publications by authors named "Aaron Gitler"

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder typically characterized by insoluble inclusions of hyperphosphorylated TDP-43. The mechanisms underlying toxic TDP-43 accumulation are not understood. Persistent activation of p38 mitogen-activated protein kinase (MAPK) is implicated in ALS.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers discovered that "cryptic exons" can be used to create therapies that specifically target unhealthy neurons affected by motor neuron diseases.
  • This selective approach aims to minimize side effects and improve the effectiveness of treatments.
  • The study highlights the potential for using genetic mechanisms to enhance therapy delivery, thereby offering new hope for patients suffering from these conditions.
View Article and Find Full Text PDF

Neurons are long-lived, terminally differentiated cells with limited regenerative capacity. Cellular stressors such as endoplasmic reticulum (ER) protein folding stress and membrane trafficking stress accumulate as neurons age and accompany age-dependent neurodegeneration. Current strategies to improve neuronal resilience are focused on using factors to reprogram neurons or targeting specific proteostasis pathways.

View Article and Find Full Text PDF

Background: Many neurodegenerative disease treatments, such as deep brain stimulation for Parkinson's Disease, can alleviate symptoms by primarily compensating for circuit dysfunctions. However, the stimulation's effect on the underlying disease progression remains relatively unknown. Here, we report that neuromodulation can not only modulate circuit function but also modulate the in vivo spreading dynamics of α-synuclein pathology, the primary pathological hallmark observed in Parkinson's Disease.

View Article and Find Full Text PDF
Article Synopsis
  • In frontotemporal lobar degeneration (FTLD), abnormal protein buildup in the brain correlates with declines in social-emotional and language skills, primarily involving TDP-43 or tau proteins.
  • The study investigates how degeneration patterns in FTLD relate to gene expression of recently evolved genetic regions, using neuroimaging and transcriptomic data to examine targeted brain areas.
  • Results indicate that FTLD subtypes uniquely or overlappingly affect brain regions tied to genes evolved in humans, with a notable relationship between TDP-43 function impairment and cryptic splicing in affected genes.
View Article and Find Full Text PDF
Article Synopsis
  • The letter discusses how new types of cryptic proteins produced by TDP-43 dysfunction could indicate TDP-43-related issues in neurodegenerative diseases.
  • It highlights the significance of these novel proteins as potential biomarkers for diagnosing or understanding these diseases.
  • The findings could lead to improved methods for detecting and studying conditions linked to TDP-43 pathology, such as ALS and frontotemporal dementia.
View Article and Find Full Text PDF

Motor neurons (MNs) constitute an ancient cell type targeted by multiple adult-onset diseases. It is therefore important to define the molecular makeup of adult MNs in animal models and extract organizing principles. Here, we generate a comprehensive molecular atlas of adult Caenorhabditis elegans MNs and a searchable database.

View Article and Find Full Text PDF

In frontotemporal dementia and amyotrophic lateral sclerosis, the RNA-binding protein TDP-43 is depleted from the nucleus. TDP-43 loss leads to cryptic exon inclusion but a role in other RNA processing events remains unresolved. Here, we show that loss of TDP-43 causes widespread changes in alternative polyadenylation, impacting expression of disease-relevant genes (e.

View Article and Find Full Text PDF
Article Synopsis
  • Frontotemporal lobar degeneration (FTLD) is a disease that affects how people think and communicate, causing issues in emotions and language.
  • Researchers studied brain regions affected by FTLD to see if they are linked to special human genes that have changed through evolution.
  • They found that certain genes related to brain functions are targeted by different types of FTLD, suggesting that this disease hits parts of the brain that have recently evolved to help humans.
View Article and Find Full Text PDF

Motor neurons (MNs) constitute an ancient cell type targeted by multiple adult-onset diseases. It is therefore important to define the molecular makeup of adult MNs in animal models and extract organizing principles. Here, we generated a comprehensive molecular atlas of adult MNs and a searchable database (http://celegans.

View Article and Find Full Text PDF

Background And Objectives: Single nucleotide variants near associate with risk of frontotemporal lobar dementia with TDP-43 inclusions (FTLD-TDP) and Alzheimer's disease (AD) in genome-wide association studies (GWAS), but the causal variant at this locus remains unclear. Here we asked whether a novel structural variant on is the causal variant.

Methods: An exploratory analysis identified structural variants on neurodegeneration-related genes.

View Article and Find Full Text PDF

Biomolecular condensation underlies the biogenesis of an expanding array of membraneless assemblies, including stress granules (SGs), which form under a variety of cellular stresses. Advances have been made in understanding the molecular grammar of a few scaffold proteins that make up these phases, but how the partitioning of hundreds of SG proteins is regulated remains largely unresolved. While investigating the rules that govern the condensation of ataxin-2, an SG protein implicated in neurodegenerative disease, we unexpectedly identified a short 14 aa sequence that acts as a condensation switch and is conserved across the eukaryote lineage.

View Article and Find Full Text PDF

Positively charged repeat peptides are emerging as key players in neurodegenerative diseases. These peptides can perturb diverse cellular pathways but a unifying framework for how such promiscuous toxicity arises has remained elusive. We used mass-spectrometry-based proteomics to define the protein targets of these neurotoxic peptides and found that they all share similar sequence features that drive their aberrant condensation with these positively charged peptides.

View Article and Find Full Text PDF

Hexanucleotide repeat expansion (HRE) within is the most common genetic cause of frontotemporal dementia (FTD). Thalamic atrophy occurs in both sporadic and familial FTD but is thought to distinctly affect HRE carriers. Separately, emerging evidence suggests widespread derepression of transposable elements (TEs) in the brain in several neurodegenerative diseases, including HRE-mediated FTD (C9-FTD).

View Article and Find Full Text PDF

In this issue of Molecular Cell, Gropp et al. identify how the cellular background affects whether or not the Huntington's disease protein will form toxic pathological aggregates, providing insight into selective neuronal vulnerability in neurodegenerative disease.

View Article and Find Full Text PDF

An emerging view regarding neurodegenerative diseases is that discreet seeding of misfolded proteins leads to widespread pathology. However, the mechanisms by which misfolded proteins seed distinct brain regions and cause differential whole-brain pathology remain elusive. We used whole-brain tissue clearing and high-resolution imaging to longitudinally map pathology in an α-synuclein pre-formed fibril injection model of Parkinson's disease.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers are exploring gene-based therapies to reduce ataxin-2 levels for treating neurodegenerative diseases like ALS and SCA2.
  • A genome-wide study identified the RTN4R gene, which influences ataxin-2 levels, and demonstrated that targeting this gene can effectively lower ataxin-2 in both human and mouse neurons.
  • The findings suggest that targeting the RTN4/NoGo-Receptor could be a new treatment strategy for ALS and SCA2, as reducing either RTN4 or ataxin-2 promotes better axonal regeneration after nerve injury.
View Article and Find Full Text PDF

Mutations in the ataxin-2 gene (ATXN2) cause the neurodegenerative disorders amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia type 2 (SCA2). A therapeutic strategy using antisense oligonucleotides targeting ATXN2 has entered clinical trial in humans. Additional ways to decrease ataxin-2 levels could lead to cheaper or less invasive therapies and elucidate how ataxin-2 is normally regulated.

View Article and Find Full Text PDF

Intracellular phase separation is emerging as a universal principle for organizing biochemical reactions in time and space. It remains incompletely resolved how biological function is encoded in these assemblies and whether this depends on their material state. The conserved intrinsically disordered protein PopZ forms condensates at the poles of the bacterium Caulobacter crescentus, which in turn orchestrate cell-cycle regulating signaling cascades.

View Article and Find Full Text PDF